Show simple item record

dc.contributor.authorGuzmán, Eduardo
dc.contributor.authorMaestro Martín, Armando
dc.date.accessioned2022-08-31T11:33:23Z
dc.date.available2022-08-31T11:33:23Z
dc.date.issued2022-08-17
dc.identifier.citationTechnologies 10(4) : (2022) // Article ID 96es_ES
dc.identifier.issn2227-7080
dc.identifier.urihttp://hdl.handle.net/10810/57378
dc.description.abstractSynthetic micro/nanomotors (MNMs) are human-made machines characterized by their capacity for undergoing self-propelled motion as a result of the consumption of chemical energy obtained from specific chemical or biochemical reactions, or as a response to an external actuation driven by a physical stimulus. This has fostered the exploitation of MNMs for facing different biomedical challenges, including drug delivery. In fact, MNMs are superior systems for an efficient delivery of drugs, offering several advantages in relation to conventional carriers. For instance, the self-propulsion ability of micro/nanomotors makes possible an easier transport of drugs to specific targets in comparison to the conventional distribution by passive carriers circulating within the blood, which enhances the drug bioavailability in tissues. Despite the promising avenues opened by the use of synthetic micro/nanomotors in drug delivery applications, the development of systems for in vivo uses requires further studies to ensure a suitable biocompatibility and biodegradability of the fabricated engines. This is essential for guaranteeing the safety of synthetic MNMs and patient convenience. This review provides an updated perspective to the potential applications of synthetic micro/nanomotors in drug delivery. Moreover, the most fundamental aspects related to the performance of synthetic MNMs and their biosafety are also discussed.es_ES
dc.description.sponsorshipThis work was funded in part by MICINN under Grant PID2019-106557GB-C21 and by E.U. on the framework of the European Innovative Training Network—Marie Sklodowska-Curie Action Nano Paint (Grant Agreement 955612).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/955612es_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2019-106557GB-C21es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectbiomedicinees_ES
dc.subjectdrug deliveryes_ES
dc.subjectmachineses_ES
dc.subjectmicro/nanomotorses_ES
dc.subjectnanomedicinees_ES
dc.subjectpropulsiones_ES
dc.titleSynthetic Micro/Nanomotors for Drug Deliveryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2022-08-25T11:17:58Z
dc.rights.holder© 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2227-7080/10/4/96es_ES
dc.identifier.doi10.3390/technologies10040096
dc.contributor.funderEuropean Commission


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).